RecruitingPhase 3NCT07525219

Suzetrigine Frame Trial Comparing Suzetrigine and Acetaminophen

A Randomized Controlled Trial Comparing Suzetrigine and Acetaminophen for Reducing Pain During Local Anesthetic Infiltration and Head Frame Application


Sponsor

Wake Forest University Health Sciences

Enrollment

80 participants

Start Date

Jun 22, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Local anesthetic infiltration is a primary source of acute pain during stereotactic procedures.


Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Suzetrigine and a drug called acetaminophen for people with analgesic efficacy. The study is currently recruiting participants at 1 location. People eligible for this study include aged 21 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGSuzetrigine

100mg - Medication is self-administered at home on an empty stomach approximately 1-6 hours prior to the procedure.

DRUGacetaminophen

1000mg - Medication is self-administered at home on an empty stomach approximately 1-6 hours prior to the procedure.


Locations(1)

Wake Forest University Health Sciences

Winston-Salem, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07525219


Related Trials